Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Discovering New Liver Disease Treatments

June 29, 2018

Discovering New Liver Disease Treatments

Non-alcoholic fatty liver disease is set to become the most common cause of liver transplant in the coming decade. Although almost one-third of adults worldwide suffer from the condition, which is also associated with diabetes and obesity, there are currently no approved treatments. This podcast will discuss the basis of liver disease as well as several cutting edge approaches that are being developed to model the disease and speed the discovery of new therapeutics.

This podcast has been made possible with support from Emulate.